Dr. Mak Jawadekar has been serving as a strategic advisor to pharmaceutical and biotechnology companies through his independent consultancy since 2010. He has over 35 years of experience in the Pharma Industry spanning both Business and Research activities. He has extensive experience in joint ventures, alliance management, contracting, outsourcing, benchmarking, performance metrics, pharmaceutical research and development, drug delivery technologies, formulations, clinical supply manufacturing and packaging, clinical trial materials, pharmaceutics, and pharmaceutical sciences. He also has deep knowledge and global experience working across the United States, Europe, India, and other parts of Asia, including Japan and China. He has helped create several Pharma R&D Partnerships, Joint Ventures, and Collaborations during his career.
Prior to his consultancy practice, Dr. Jawadekar was at Pfizer, Inc., as Director, Portfolio Management & Analytics, and as Vice President, Asia Colleague Resource Group, in the Pfizer Global R&D division. Mak held roles of increasing responsibility from 1982 to 20100 while at Pfizer, in technical, management, and business development positions. In these roles, he has worked in the areas of Drug Delivery Technology Assessment, Strategic External Alliance Management, Strategic CMC, Pharma R&D, Clinical Manufacturing, Manufacturing Technology Transfer, and Scale-up, beginning as a research scientist in formulations development.
Dr. Jawadekar has presented at many professional meetings and has participated in various Panel Discussions/Round Tables around the globe. US President George W. Bush invited Dr. Jawadekar to accompany him on a trip to India in 2006. Recently, he accompanied Honorable Congressman Todd Rokita (R) Indiana, on a business mission to India in 2019. He has accompanied Presidents of Pfizer R &D to India in 2007 and also in 2009. In February 2018, he worked with Mr. Tonino Lamborghini, Chairman, Tonino Lamborghini S.p.A. of Italy to establish strategic collab0 rations in India, working through India's Prime Minister Narendra Modi.
Mak holds a Ph.D. in Pharmaceutics from the University of Minnesota and was honored with an honorary D.Sc. degree by DYP Mumbai University, recommended by the President of India, in February 2011.
This person is not in the org chart